U.S. Medical Panel Endorses At-Home Test for Cervical Cancer Screening

A leading U.S. medical panel now says that for many women, collecting their own sample at home is a safe and effective alternative to a clinic-based Pap smear for cervical cancer screening. The new guidelines endorse the use of a self-swab test, which detects the human papillomavirus (HPV). HPV causes nearly all cervical cancers. This recommendation follows the first federal approval of such an at-home test earlier this year. Experts say this shift could significantly increase screening rates. It may help women who face barriers to clinic visits, such as lack of transportation, time, or access to a specialist. The self-test is currently recommended as an option, not a replacement, for regular screening. Healthcare providers will still guide patients on the best method for their individual health needs.